Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out if rhIL-11（Interleukin 11） may
increase the platelet count in Childhood patients with acute lymphocytic leukemia (ALL) who
develop low platelet counts while receiving standard CAT（cyclophosphamide+Cytosine
arabinoside+mercaptopurine，7d） therapy.